RCA Laboratory Services LLC – Trademark Portfolio
Entity Type: 16
RCA Laboratory Services LLC holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 8 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include GENETWORX and EFFECTIVERX. The owner is based in Glen Allen, VA.
4060 Innslake Dr
Glen Allen, VA 23060
Showing of trademarks Trademarks
Trademark Classifications
RCA Laboratory Services LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does RCA Laboratory Services LLC have?
RCA Laboratory Services LLC has 9 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 5 abandoned, 1 cancelled.
What trademark classes does RCA Laboratory Services LLC file in?
RCA Laboratory Services LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are RCA Laboratory Services LLC's most well-known trademarks?
RCA Laboratory Services LLC's registered trademark portfolio includes well-known marks such as GENETWORX and EFFECTIVERX. These are among 2 currently registered trademarks in the portfolio.
What is RCA Laboratory Services LLC's trademark registration success rate?
RCA Laboratory Services LLC has a 25% trademark registration rate, with 2 out of 8 resolved applications resulting in successful registration. Currently, 1 application is pending review.